John Robert Reinsberg

Lazard Asset Management LLC (LAM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1970 and is a wholly-owned subsidiary of Lazard Frères & Co. LLC, ultimately held by Lazard Ltd. (NYSE: LAZ). LAM provides investment advisory services to a variety of clients.

Alliance for Cancer Gene Therapy, Inc. provides funding for cancer research. The non-profit company is based in Stamford, CT. The company was founded by Edward Netter. Kevin Honeycutt has been the CEO of the company since 2018.

Lazard Alternative Strategies 1099 Fund is a non diversified closed-end management investment company. Its investment objective to achieve long-term capital appreciation. The company was founded on June 28, 2011 and is headquartered in New York, NY.

Part of Lazard Ltd., Lazard Fund Managers Ltd. is a British company that functions as an investment holding company. The company is based in London, UK and was founded in 1985.

Part of Lazard Ltd., Lazard Asset Management (UK) Holdings Ltd. functions as a holding British company. The company is based in London, UK. It was founded in 2002.

Part of Jardine Matheson Holdings Ltd., Jardine Matheson & Co. Ltd. is an investment holding company based in Hong Kong, Hong Kong. The Chinese company was founded in 1906 by William Jardine and operates with interests in air cargo terminal operation.

Hill & Knowlton, Inc. engages in the provision of international communications consultancy services. The company was founded in 1927 and is headquartered in New York, NY.